Liu Yuan, Ding Ning, Zhou Shixiang, Chen Chen, Huang Shan, Lv Yanling, Jiao Damin, Zheng Yishan, Hu Zhiliang, Xu Chuanjun, Chen Wei, Dai Hui, Sun Wenkui, Cheng Cong, Lv Ru, Cheng Jian, Ye Zi, Li Zhengjie, Yi Yongxiang, Wei Hongxia
Department of Infectious Disease, The Second Hospital of Nanjing, Nanjing University of Chinese Medicine, Nanjing, China.
Department of Respirology and Critical Care Medicine, The First Affiliated Hospital of Nanjing Medical University; Nanjing, China.
J Thorac Dis. 2020 Nov;12(11):6435-6445. doi: 10.21037/jtd.2020.04.17.
The epidemiological and clinical characteristics of patients with coronavirus disease 2019 (COVID-19) have been reported. However, the prevalence of retesting positive by RT-PCR for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and the associated patient characteristics, remain unclear.
We included 90 confirmed cases of COVID-19 treated in the Nanjing Public Health Center from January 20, 2020 to February 16, 2020 in this retrospective study. All patients completed treatment for COVID-19 and were retested by RT-PCR for SARS-CoV-2 4-20 days after completion of therapy. The clinical characteristics between patients with who retested positive versus negative by RT-PCR were compared, and the factors predictive of positive retesting were analyzed. Positive retesting was modeled with the area under the receiver operating characteristic curve (AUC).
The age range of the study population was 0.8-97 years, and all patients were cured or showed improvement. A total of 10 (11%) patients retested positive by RT-PCR 4-20 days after completion of therapy. As compared with patients who retested negative, those who retested positive had a lower percentage of pre-admission fever, a higher percentage of post-admission fever, a lower percentage of bilateral lung infection, higher white blood cell (WBC) count and creatine phosphokinase, and lower hypersensitive c-reactive protein (hs-CRP), interleukin-6 and erythrocyte sedimentation rates (all P<0.05). Logistic regression analysis of the above eight key variables showed that lower hs-CRP and higher WBC were independently associated with positive retesting by RT-PCR. A combination of hs-CRP and WBC were predictive of positive retesting, with an AUC of 0.859.
Patients with COVID-19 who retested positive by RT-PCR for SARS-CoV-2 had mild symptoms and better blood testing results. A combination of hs-CRP and WBC may predict positive retesting by RT-PCR; however, the sensitivity and specificity should be studied further.
2019年冠状病毒病(COVID-19)患者的流行病学和临床特征已有报道。然而,严重急性呼吸综合征冠状病毒2(SARS-CoV-2)逆转录聚合酶链反应(RT-PCR)复阳率及其相关患者特征仍不清楚。
本回顾性研究纳入了2020年1月20日至2020年2月16日在南京市公共卫生中心接受治疗的90例确诊COVID-19病例。所有患者均完成COVID-19治疗,并在治疗结束后4至20天接受SARS-CoV-2的RT-PCR复测。比较RT-PCR复测阳性和阴性患者的临床特征,并分析预测复测阳性的因素。采用受试者操作特征曲线(AUC)下面积对复测阳性进行建模。
研究人群年龄范围为0.8至97岁,所有患者均治愈或病情好转。共有10例(11%)患者在治疗结束后4至20天RT-PCR复测呈阳性。与复测阴性的患者相比,复测阳性的患者入院前发热百分比更低,入院后发热百分比更高,双侧肺部感染百分比更低,白细胞(WBC)计数和肌酸磷酸激酶更高,超敏C反应蛋白(hs-CRP)、白细胞介素-6和红细胞沉降率更低(均P<0.05)。对上述八个关键变量进行逻辑回归分析表明,较低的hs-CRP和较高的WBC与RT-PCR复测阳性独立相关。hs-CRP和WBC联合可预测复测阳性,AUC为0.859。
SARS-CoV-2的RT-PCR复测呈阳性的COVID-19患者症状较轻,血液检测结果较好。hs-CRP和WBC联合可能预测RT-PCR复测阳性;然而,其敏感性和特异性有待进一步研究。